서재홍 프로필 사진

서재홍

Seo, Jae Hong

대학원

의과학과

연구분야

  • Cancer Stem Cell, 
  • HSP90 inhibitor, 
  • HSP90 inhibitor, 
  • New Drug Development in TNBC, 
  • 삼중음성유방암에서 신약개발연구, 
  • 암줄기세포

자료 필터

자료유형

발행연도

1998 ~ 2026
1998 2026

키워드

언어

선택된 필터

  • article
  • conference
  • book

전체 144건 중 1번부터 10번까지의 결과를 표시합니다.

2026
Article

Ebastine targets HER2/HER3 signaling and cancer stem cell traits to overcome trastuzumab resistance in HER2-positive breast cancer

  • Jung, Eunsun ; 
  • Kim, Ji Young ; 
  • Ko, Dongmi ; 
  • Seo, Juyeon ; 
  • Lee, Sang Yoon ; 
  • ... Seo, Jae Hong ; 
  • 외 9명
  • 2026-04
  • International Journal of Molecular Medicine
  • SPANDIDOS PUBL LTD
Article

C-terminal HSP90 inhibitor NCT-58 impairs the cancer stem-like phenotype and enhances chemotherapy efficacy in TNBC

  • Jung, Eunsun ; 
  • Kim, Yoon-Jae ; 
  • Lee, Kyoungmin ; 
  • Jang, Seojin ; 
  • Park, Soeun ; 
  • ... Seo, Jae Hong ; 
  • 외 12명
  • 2026-01
  • Oncology Reports
  • SPANDIDOS PUBL LTD
2025
Article

Pitavastatin is a novel Mcl-1 inhibitor that overcomes paclitaxel resistance in triple-negative breast cancer

  • Ko, Dongmi ; 
  • Park, Soeun ; 
  • Park, Minsu ; 
  • Kim, Seongjae ; 
  • Park, Jung Min ; 
  • ... Seo, Jae Hong ; 
  • 외 7명
  • 2025-10-22
  • Experimental Hematology & Oncology
  • BMC
2024
Article

Discovery of indazole inhibitors for heat shock protein 90 as anti-cancer agents

  • La, Minh Thanh ; 
  • Hoang, Van-Hai ; 
  • Sahu, Raghaba ; 
  • Nguyen, Cong-Truong ; 
  • Nam, Gibeom ; 
  • ... Seo, Jae Hong ; 
  • 외 6명
  • 2024-10-05
  • European Journal of Medicinal Chemistry
  • ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
Article

Neoadjuvant-adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial

  • Huang, Liang ; 
  • Pang, Da ; 
  • Yang, Hongjian ; 
  • Li, Wei ; 
  • Wang, Shusen ; 
  • ... Seo, Jae Hong ; 
  • 외 18명
  • 2024-03-09
  • Nature Communications
  • NATURE PORTFOLIO
Article

Long-term patient-reported outcomes from monarchE: Abemaciclib plus endocrine therapy as adjuvant therapy for HR+, HER2-, node-positive, high-risk, early breast cancer

  • Tolaney, Sara M. ; 
  • Guarneri, Valentina ; 
  • Seo, Jae Hong ; 
  • Cruz, Josefina ; 
  • Abreu, Miguel Henriques ; 
  • 외 11명
  • 2024-03
  • European Journal of Cancer
  • ELSEVIER SCI LTD
Article

The HSP90 inhibitor HVH-2930 exhibits potent efficacy against trastuzumab-resistant HER2-positive breast cancer

  • Park, Minsu ; 
  • Jung, Eunsun ; 
  • Park, Jung Min ; 
  • Park, Soeun ; 
  • Ko, Dongmi ; 
  • ... Seo, Jae Hong ; 
  • 외 14명
  • 2024
  • Theranostics
  • IVYSPRING INT PUBL
2023
Article

Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR

  • Kim, Seongjae ; 
  • Park, Jung Min ; 
  • Park, Soeun ; 
  • Jung, Eunsun ; 
  • Ko, Dongmi ; 
  • ... Seo, Jae Hong ; 
  • 외 8명
  • 2023-11-04
  • Journal of Experimental and Clinical Cancer Research
  • BMC
Article

Ebastine impairs metastatic spread in triple-negative breast cancer by targeting focal adhesion kinase

  • Seo, Juyeon ; 
  • Park, Minsu ; 
  • Ko, Dongmi ; 
  • Kim, Seongjae ; 
  • Park, Jung Min ; 
  • ... Seo, Jae Hong ; 
  • 외 8명
  • 2023-05-01
  • Cellular and Molecular Life Sciences
  • SPRINGER BASEL AG
Article

Cutting Off H plus Leaks on the Inner Mitochondrial Membrane: A Proton Modulation Approach to Selectively Eradicate Cancer Stem Cells

  • 2023-03-01
  • Journal of the American Chemical Society
  • AMER CHEMICAL SOC
1